Literature DB >> 16204026

Fhit and CHK1 have opposing effects on homologous recombination repair.

Baocheng Hu1, Hongyan Wang, Xiang Wang, Hua-Rui Lu, Cuifen Huang, Simon N Powell, Kay Huebner, Ya Wang.   

Abstract

Fragile histidine triad (FHIT) gene deletion or promoter methylation and reduced Fhit protein expression occur in approximately 70% of human epithelial tumors and, in some cancers, are clearly associated with tumor progression. Specific Fhit signal pathways have not been identified. We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage. In this study, we show that cells, with or without Fhit expression, have similar DNA double-strand break induction levels and similar rejoining rates following ionizing radiation, indicating that the effect of Fhit on cell radiosensitivity is independent of nonhomologous end-joining. By combining I-SceI-induced-DNA double-strand break system and small interfering RNA approach, we also show that knocking down Fhit increases the efficiency of homologous recombination repair of cells, but knocking down Chk1 decreases the efficiency of homologous recombination repair, associated with the sensitivity to ionizing radiation-induced killing. Taken together, the results show that the role of Fhit in affecting the sensitivity of cells to ionizing radiation-induced killing is through the CHK1 pathway linked to homologous recombination repair. These results also illustrate the importance of balanced checkpoint activation in genomic stability and suggest a connection between the radioresistance and mutagenesis, carcinogenesis, as well as tumor progression in Fhit-deficient cells or tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204026     DOI: 10.1158/0008-5472.CAN-05-1966

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.

Authors:  Tobias Menzel; Viola Nähse-Kumpf; Arne Nedergaard Kousholt; Ditte Kjærsgaard Klein; Christin Lund-Andersen; Michael Lees; Jens Vilstrup Johansen; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

Review 2.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

3.  MicroRNA-376a sensitizes cells following DNA damage by downregulating MEPE expression.

Authors:  Jipo Sheng; Wei Luo; Fang Yu; Ning Gao; Baocheng Hu
Journal:  Cancer Biother Radiopharm       Date:  2013-04-09       Impact factor: 3.099

4.  A small peptide mimicking the key domain of MEPE/OF45 interacting with CHK1 protects human cells from radiation-induced killing.

Authors:  Xiaoyan Yu; Hongyan Wang; Shuang Liu; Xiangming Zhang; Peter Guida; Baocheng Hu; Ya Wang
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

5.  Rad17 recruits the MRE11-RAD50-NBS1 complex to regulate the cellular response to DNA double-strand breaks.

Authors:  Qinhong Wang; Michael Goldstein; Peter Alexander; Timothy P Wakeman; Tao Sun; Junjie Feng; Zhenkun Lou; Michael B Kastan; Xiao-Fan Wang
Journal:  EMBO J       Date:  2014-02-16       Impact factor: 11.598

6.  miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks.

Authors:  Baocheng Hu; Xiang Wang; Shuofeng Hu; Xiaomin Ying; Ping Wang; Xiangming Zhang; Jian Wang; Hongyan Wang; Ya Wang
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

7.  PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpoints.

Authors:  Zhoushuai Qin; Zhiqiang Bai; Ying Sun; Xiaohong Niu; Wei Xiao
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

8.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

9.  MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers.

Authors:  P Zhang; H Wang; P S N Rowe; B Hu; Y Wang
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.

Authors:  Shuang Liu; Hongyan Wang; Xiang Wang; Lin Lu; Ning Gao; Peter S N Rowe; Baocheng Hu; Ya Wang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.